SXTC
China SXT Pharmaceuticals, Inc.
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · CN
$2.23
+1.36%Latest reported
- Last report date
- Mar 30, 2019
- EPS actual
- $0.07
- EPS estimate
- —
- Revenue actual
- $7.0M
- Revenue estimate
- —
Track record
Trailing twelve quarters
- EPS beats (12Q)
- —
- EPS misses (12Q)
- —
- EPS in line (12Q)
- —
- Avg surprise (4Q)
- —
- Revenue beats (12Q)
- —
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Jul 30, 2026